Generic Drugs

Mark Cuban-Owned Company To Launch Pharmacy Benefit Management Services

Kodak CEO Says Moving Forward On Generic Drug Ingredients Venture, With or Without Federal Loan

US Indicts Teva Pharmaceutical In Generic Drug Price-Fixing Case

Kodak CEO Says Moving Forward On Generic Drug Ingredients Venture, With or Without Federal Loan

US Indicts Teva Pharmaceutical In Generic Drug Price-Fixing Case

Teva CEO Kare Schultz On Drugmaker's Outlook, Coronavirus Response

Teva Plummets Amid Massive Price Fixing Scheme; Other Generic Drugmakers Also Fall

Teva CEO Kare Schultz On Drugmaker's Outlook, Coronavirus Response

Teva Plummets Amid Massive Price Fixing Scheme; Other Generic Drugmakers Also Fall

Baird: What Rite Aid's Renewed Deal With Distributor McKesson Means For Both Companies

Global Appeal In A Generics ETF

Generic Drugs Recent News

Goldman Sachs On Specialty Pharma: Buy Catalent, Sell Valeant

Teva's Cost-Cutting Plan Nets A Mizuho Upgrade

Mallinckrodt Sees Slight Positive From Tax Reform, Up To $500 Million Benefit

Goldman Sachs: Now Is The Time To Get In On Teva's Turnaround

Analyst: Despite Industry Woes, Investigations, And Management Shake-Up, Perrigo Is A Buy

For Teva Pharmaceuticals, No Recovery In Sight, Says Analyst

RBC: Perrigo's Near-Term Risk Lessens, But Long-Term Issues Persist

Analyst Eats 'Some Humble Pie,' Says Teva Needs To Deliver On Greater Visibility In Coming Months

Adamas Pharma's Gocovri Will Achieve 'Blockbuster' Status, Says Kerrisdale

Endo International Piques Investor Interest After Raising Guidance

Why Is Teva Falling? Competition

What Approval For Generic Copaxone Means For Mylan

A Look At Teva's Paragard IUD Asset Sale To Cooper Companies, From Both Sides

Teva's New CEO Is A Positive Catalyst

Mylan's Stock Is No Longer A Buy According To Analysts At Argus

Teva Downgraded As Analyst Casts Doubt On Turnaround Story

Teva's Quarter: Earnings Miss, Guidance Cut, Dividend Devastated

Teva's Stock Inches Higher Amid Cost-Cutting Plan

Citron On Lannett: Price Gouging At Its Worst, Will Be First To Go Bankrupt

Teva Pharmaceuticals Hit With A Slew Of Downgrades Following Guidance Revision

Report: Teva Looking To Win Early EU Approval For Its Acquisition Of Allergan's Generics Unit

AstraZeneca Falls More Than 5% Following Q4 Print

Express Scripts Calls Out Valeant, Says It's 'Holding Pharmaceutical Manufacturers Accountable For Excessive Price Hikes'